Streetbeat News

Analyst Ratings

ABBV

GS

TSM

On CNBC's 'Halftime Report Final Trades,' analysts recommended Taiwan Semiconductor Manufacturing (TSM), AbbVie (ABBV), and Goldman Sachs (GS). TSM is expected to announce a second Japanese plant, which could boost its stock. AbbVie, with an upgraded rating from William Blair and upcoming earnings release, is also favored. Goldman Sachs is seeking new talent to grow its asset and wealth management divisions, which recently saw a 23% revenue surge. All three companies experienced slight stock price movements on Monday.

Portfolio Pulse from Avi Kapoor

January 30, 2024 | 2:00 pm

MYGN

Goldman Sachs analyst Matthew Sykes has reaffirmed a Buy rating on Myriad Genetics (NASDAQ:MYGN) and increased the price target from $28 to $31.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:59 pm

GH

Goldman Sachs analyst Matthew Sykes has maintained a Buy rating on Guardant Health (NASDAQ:GH) but reduced the price target from $43 to $37.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:58 pm

GPRE

Goldman Sachs analyst Adam Samuelson has maintained a Buy rating on Green Plains (NASDAQ:GPRE) but reduced the price target from $39 to $34.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:57 pm

PNST

Oppenheimer analyst Brian Bittner has initiated coverage on Pinstripes Holdings (NYSE:PNST) with an Outperform rating and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:56 pm

FFIV

Goldman Sachs analyst Michael Ng has maintained a Neutral rating on F5 Networks, Inc. (NASDAQ: FFIV) and increased the price target from $156 to $179.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:52 pm

AMD

NVDA

Ahead of its Q4 earnings release, AMD received a downgrade from Raymond James analyst Srini Pajjuri, changing from a Strong Buy to Outperform, with a price target increase from $190 to $195. The downgrade is due to high AI revenue expectations, with AMD's stock trading at 33 times the adjusted non-GAAP estimates for 2025, which already discounts a 20% unit share for AI GPUs. Pajjuri compares AMD's valuation to Nvidia's, noting that Nvidia is likely to have shipped more AI chips and is on track to increase shipments, while AMD capturing 20% of the AI chip market is seen as challenging. AMD is expected to report non-GAAP earnings per share of 77 cents on revenue of $6.12 billion. AMD shares fell 0.41% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

January 30, 2024 | 1:51 pm

CRWD

Raymond James analyst Adam Tindle has initiated coverage on CrowdStrike Holdings (NASDAQ:CRWD) with an Outperform rating and set a price target of $330.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:48 pm

USCB

Keefe, Bruyette & Woods analyst Brady Gailey has maintained an Outperform rating on USCB Financial Holdings (NASDAQ:USCB) and increased the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:48 pm

RNST

Keefe, Bruyette & Woods analyst Catherine Mealor maintains a Market Perform rating on Renasant (NYSE:RNST) and increases the price target from $34 to $35.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:46 pm